Skip to main content

Table 4 Maternal outcomes

From: Different azithromycin protocols for management of preterm prelabour rupture of membranes: a randomized clinical trial

Maternal outcomes

Group I

(n = 105)

Group II

(n = 105)

P-value

Latency period (days)

  Mean ± SD

5.80 ± 5.44

2.88 ± 2.37

0.0001*

  Median (Range)

4.0 (1.8–29.0)

2.5 (1.5–19.0)

 

Chorioamnionitis, n (%)

  Yes

8 (7.6%)

12 (11.4%)

0.347

  No

97 (92.4%)

93 (88.6%)

 

Mode of delivery, n (%)

  NVD

35 (33.3%)

45 (42.9%)

0.155

  CS

70 (66.7%)

60 (57.1%)

 

Gestational age at time of delivery (weeks)

  Mean ± SD

35.12 ± 2.86

32.61 ± 3.86

0.0001*

  Range

25.0–37.0

25.0–37.0

 

Gestational age groups:

  24–28+6 wks

5 (4.8%)

11 (10.4%)

0.001

  29–32+6 wks

12 (11.4%)

30 (28.6%)

 

  33–36+6 wks

88 (83.8%)

64 (61%)

 

Postpartum endometritis, n (%)

  Yes

3 (2.9%)

15 (14.3%)

0.003*

  No

102 (97.1%)

90 (85.7%)

 
  1. * Statistically significant difference (P < 0.05)
  2. CS Caesarian section, NVD Normal vaginal delivery, n (%) Number and percentage, SD Standard deviation